Safety and Efficacy of Elbasvir/Grazoprevir in Patients With Hepatitis C Virus Infection and Compensated Cirrhosis: An Integrated Analysis. [electronic resource]
Producer: 20170808Description: 1372-1382.e2 p. digitalISSN:- 1528-0012
- Adult
- Aged
- Aged, 80 and over
- Amides
- Antiviral Agents -- adverse effects
- Benzofurans -- adverse effects
- Carbamates
- Clinical Trials, Phase II as Topic
- Clinical Trials, Phase III as Topic
- Cyclopropanes
- Drug Combinations
- Drug Resistance, Viral -- genetics
- Drug Therapy, Combination
- Female
- Hepacivirus -- genetics
- Hepatitis C, Chronic -- complications
- Humans
- Imidazoles -- adverse effects
- Liver Cirrhosis -- physiopathology
- Male
- Middle Aged
- Quinoxalines -- adverse effects
- RNA, Viral -- blood
- Randomized Controlled Trials as Topic
- Retreatment
- Retrospective Studies
- Ribavirin -- therapeutic use
- Sulfonamides
- Sustained Virologic Response
- Viral Nonstructural Proteins -- genetics
- Young Adult
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.